News
Nordic Life Science Days 2023
This year’s Nordic Life Science Days took place in Copenhagen on 29-30 November. Since 2015, Oslo Cancer Cluster has coordinated the joint booth Norway for Life Science, promoting the Norwegian healthcare and life science industry. This year together with Norway Health Tech, The Life Science Cluster, Norwegian Smart Care Cluster, Centre for Digital Life Norway, […]
Six-month milestone
The foundations of the ECHoS project are laid and Cancer Mission activities are speeding up in Norway.
Personalising breast cancer screening in Norway
Are polygenic risk scores the answer?
New incubator board member
Thomas London has joined the board of Oslo Cancer Cluster Incubator.
CellFIT workshop in Trondheim
How can manufacturing of T cell therapies be improved?
First demonstration of universal cancer vaccine
New data shows 27% improved survival in the NIPU trial.
Statsbudsjettet 2024
Her er de viktigste sakene i Statsbudsjettet 2024 for Oslo Cancer Clusters medlemmer.
SurViva joins Oslo Cancer Cluster
SurViva is a Norwegian consultancy providing quality guidance for life science companies.
New research on genetic risk and breast cancer
New Norwegian research in polygenic risk score
A roadmap for the health industry
What is the government's ambition for the health industry?
Personalised medicine to relieve the health service
Smaller patient groups and targeted treatments are the future of cancer care in Norway. It is no longer a question of if but when personalised medicine will be a reality for all cancer patients in Norway. This was a key message in a recent meeting arranged by the public-private consortium CONNECT during Arendalsuka, where the […]
Arendalsuka: – We need to attract the big companies
How will Norway implement the Mission on Cancer?
